CMPX
NASDAQStockCompass Therapeutics, Inc.
$5.14-0.05 (-0.96%)
52-Week Range
$1.46
$6.69
Key Stats
Market Cap
710.8M
P/E Ratio
—
Dividend Yield
—
Beta
1.29
Volume
674.4K
Avg Volume
2.2M
Performance
1M
-17.36%
3M
+2.17%
6M
+43.77%
YTD
+0.39%
1Y
+120.85%
3Y
+51.75%
5Y
+46.20%
Price Chart
ETF Exposure
CMPX is held by 66 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
PreviousPage 2 of 2
About CMPX ETF Exposure
Compass Therapeutics, Inc. (CMPX) is held by 66 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 710.8M, CMPX is a widely held institutional stock. The stock currently trades at $5.14. Investors can gain exposure to CMPX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CMPX, sorted by portfolio weight.